← Back to all signals
RESEARCH PAPER ANALYSIS

Interim Positron Emission Tomography-Adapted Treatment Strategies for Classic Hodgkin Lymphoma: Insights From Korean Real-World Data.

AI interpretation is pending for this paper.

Open original publication →
PMID42617191
JournalJournal of Korean medical science
Publication Date2026-08-17
Ingested2026-08-20 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: ABVD chemotherapy (consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine) and positron emission tomography (PET)-guided risk-adapted treatment have improved outcomes in classic Hodgkin lymphoma (cHL), but real-world evidence from Asian populations remains limited. METHODS: We retrospectively analyzed 270 patients with classical Hodgkin lymphoma treated with ABVD at two Korean tertiary centers (2015-2024). Survival analyses were performed on an intention-to-treat basis including all 270 patients. RESULTS: Among end-of-treatment (EOT) evaluable patients (n = 266), the complete response (CR) rate and overall response rate were 89.1% and 95.5%, respectively. With a median follow-up of 58.3 months, the estimated 5-year progression-free survival (PFS) and overall survival (OS) were 81.6% (95% confidence interval [CI], 75.8-86.2%) and 88.8% (95% CI, 83.6-92.4%), respectively. In the interim PET-CR subgroup (n = 200), bleomycin omission (ABVD→AVD) did not impact survival (PFS: P = 0.904; OS: P = 0.290). In multivariate analysis, male sex, an Eastern Cooperative Oncology Group (ECOG) performance status score of ≥ 2 points, and failure to achieve EOT CR were independent predictors of poor PFS, while age ≥ 65 years, extranodal involvement, and non-CR at EOT were associated with inferior OS. CONCLUSION: ABVD with PET-guided modification remains an effective and pragmatic first-line approach for cHL in Korean clinical practice. Real-world outcomes align with clinical trial data, even with limited use of novel agents. These findings support risk-adapted therapy tailored to patient response and regional treatment availability.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Journey mapping paediatric oncology care in Saudi Arabia: A mixed-methods study. Health SA = SA Gesondheid 61.1 2 Not just exotropia: a case of persistent visual complaints in a 10-year-old boy. Strabismus 48.5 3 Brainstem glioblastoma in a neurofibromatosis type 1 patient: A rare but aggressive presentation. Journal of cancer research and therapeutics 56.4 4 Immature gastric teratoma. Journal of cancer research and therapeutics 54.0 5 Microsurgical Reconstruction of the Mandible: Patient Satisfaction and Aesthetic Outcomes. The Journal of craniofacial surgery 58.2 6 Maxillary Surgical Obturator Following Resection of an Odontogenic Myxoma in a Pediatric Patient. The Journal of craniofacial surgery 56.4 7 Prognostic Models for Optimal and Improved Health-Related Quality-of-Life Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. JCO clinical cancer informatics 58.0 8 Precision post-translational modification of PML defines neuroblastoma clinical behaviour. Clinical and translational medicine 65.7 9 Case Report: Early introduction of anti-GD2 immunotherapy during induction chemotherapy in high-risk neuroblastoma: two pediatric cases. Frontiers in oncology 62.82 10 GD2-targeted immunotherapy in pediatric bone sarcomas: a systematic review of emerging strategies and combination approaches. Frontiers in immunology 87.72 11 Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells. Frontiers in immunology 83.32 12 Minimal access surgery for the combined management of oesophageal duplication cyst and congenital pulmonary airway malformation in a 4-year-old boy. Journal of minimal access surgery 49.9 13 Bilateral Knee Osteonecrosis in an Adolescent With Leukemia on Prolonged Corticosteroids: Discordant Femoral-Tibial Findings on Bone Scan SPECT-CT. Clinical case reports 58.4 14 Transforming pediatric intensive care unit outcomes in pediatric hematology-oncology and hematopoietic stem cell transplantation through golden hour care in a low- and middle-income country: a 10-year analysis. Critical care science 67.4 15 Paediatric therapeutic development workshop on osteosarcoma. British journal of cancer 74.0 16 Nutritional outcomes associated with enteral versus parenteral nutritional support during intensive induction chemotherapy for acute myeloid leukemia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 70.54 17 Circulating MicroRNAs as Diagnostic and Prognostic Biomarkers for Neuroblastoma: A Systematic Review and Exploratory Re-analysis. Molecular diagnosis & therapy 73.55 18 LACHT syndrome with branchial cyst in a female infant; case report and review of literature. BMC pediatrics 45.5 19 Enhancing Parents' Experiences of Paediatric Genomic Testing in Usual Outpatient Care: Insights From a Multi-Perspective Qualitative Study. Journal of paediatrics and child health 56.0 20 Cancer control after pausing treatment with larotrectinib in responding children with sarcoma and a TRK fusion: a plain language summary. Future oncology (London, England) 50.74 21 SRF fusion genes in myoid soft tissue tumors. The Journal of pathology 59.6 22 First-void urine and cervicovaginal brushes for vaginal microbiome profiling: a proof-of-concept study. Microbiology spectrum 62.9 23 Development and Psychometric Validation of the TF-Col: A Patient- and Caregiver-Reported Measure of Financial Toxicity in Oncology. Value in health regional issues 65.32 24 Clinical characteristics and outcomes of paediatric CNO: a retrospective cohort study with focus on zoledronic acid. Rheumatology (Oxford, England) 72.0 25 Long-Term Lung Function Monitoring after Childhood Cancer: From Risk Assessment to Prevention. Annals of the American Thoracic Society 28.5 26 Adverse Childhood Experiences and Oral Health in Adulthood. Caries research 62.5 27 Healthcare cost literacy in the united states: Cross-sectional estimates from a representative national sample. PloS one 60.6 28 Implementation of a National Pediatric Cancer Registry in Ethiopia: A systems ("A3") thinking approach. PloS one 56.4 29 A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia. Science translational medicine 86.52 30 Neighborhood factors and treatment outcomes in pediatric acute lymphoblastic leukemia: A REDIAL Consortium report. Cancer research communications 70.14 31 Presternal Subcutaneous Bronchogenic Cyst: An Unusual Ectopic Presentation Of A Congenital Lesion. Portuguese journal of cardiac thoracic and vascular surgery 37.4 32 Feasibility of 8 Gy TBI-Busulfan-Fludarabine Conditioning with Post-Transplant Cyclophosphamide for Pediatric High-Risk or Relapsed Acute Lymphoblastic Leukemia. Transplantation and cellular therapy 63.52
PATIENT-FRIENDLY SUMMARY

Interim Positron Emission Tomography-Adapted Treatment Strategies for Classic Hodgkin Lymphoma: Insights From Korean Real-World Data.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic